SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001144204-18-052994
Filing Date
2018-10-09
Accepted
2018-10-09 16:23:20
Documents
3

Document Format Files

Seq Description Document Type Size
1 F-1 tv504397_f1.htm F-1 485050
2 EXHIBIT 23.1 tv504397_ex23-1.htm EX-23.1 3952
3 EXHIBIT 23.2 tv504397_ex23-2.htm EX-23.2 5068
  Complete submission text file 0001144204-18-052994.txt   495233
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-1 | Act: 33 | File No.: 333-227752 | Film No.: 181113942
SIC: 2834 Pharmaceutical Preparations